These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
852 related items for PubMed ID: 28566298
41. Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension. Zungu-Edmondson M, Shults NV, Wong CM, Suzuki YJ. Cardiovasc Res; 2016 May 01; 110(1):30-9. PubMed ID: 26790474 [Abstract] [Full Text] [Related]
42. The importance of capillary density-stroke work mismatch for right ventricular adaptation to chronic pressure overload. Noly PE, Haddad F, Arthur-Ataam J, Langer N, Dorfmüller P, Loisel F, Guihaire J, Decante B, Lamrani L, Fadel E, Mercier O. J Thorac Cardiovasc Surg; 2017 Dec 01; 154(6):2070-2079. PubMed ID: 28712579 [Abstract] [Full Text] [Related]
43. Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension. Adão R, Mendes-Ferreira P, Maia-Rocha C, Santos-Ribeiro D, Rodrigues PG, Vidal-Meireles A, Monteiro-Pinto C, Pimentel LD, Falcão-Pires I, De Keulenaer GW, Leite-Moreira AF, Brás-Silva C. Clin Exp Pharmacol Physiol; 2019 Mar 01; 46(3):255-265. PubMed ID: 30339273 [Abstract] [Full Text] [Related]
44. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension. Kang Y, Zhang G, Huang EC, Huang J, Cai J, Cai L, Wang S, Keller BB. Am J Physiol Heart Circ Physiol; 2020 Apr 01; 318(4):H853-H866. PubMed ID: 32108526 [Abstract] [Full Text] [Related]
45. Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension. Gomez O, Okumura K, Honjo O, Sun M, Ishii R, Bijnens B, Friedberg MK. Am J Physiol Heart Circ Physiol; 2018 Mar 01; 314(3):H542-H551. PubMed ID: 29146614 [Abstract] [Full Text] [Related]
46. Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats. Yamaguchi T, Izumi Y, Yamazaki T, Nakamura Y, Sano S, Shiota M, Miura K, Iwao H, Yoshiyama M. Osaka City Med J; 2015 Jun 01; 61(1):31-41. PubMed ID: 26434103 [Abstract] [Full Text] [Related]
47. Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension. Prisco SZ, Eklund M, Moutsoglou DM, Prisco AR, Khoruts A, Weir EK, Thenappan T, Prins KW. J Am Heart Assoc; 2021 Nov 16; 10(22):e022722. PubMed ID: 34747187 [Abstract] [Full Text] [Related]
48. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats. Leong ZP, Okida A, Higuchi M, Yamano Y, Hikasa Y. Vascul Pharmacol; 2018 Jan 16; 100():41-50. PubMed ID: 29100963 [Abstract] [Full Text] [Related]
50. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension. Deng Y, Wu W, Guo S, Chen Y, Liu C, Gao X, Wei B. Respir Res; 2017 Mar 24; 18(1):53. PubMed ID: 28340591 [Abstract] [Full Text] [Related]
51. Exercise facilitates early recognition of cardiac and vascular remodeling in chronic thromboembolic pulmonary hypertension in swine. Stam K, van Duin RWB, Uitterdijk A, Cai Z, Duncker DJ, Merkus D. Am J Physiol Heart Circ Physiol; 2018 Mar 01; 314(3):H627-H642. PubMed ID: 29167118 [Abstract] [Full Text] [Related]
52. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats. Leong ZP, Hikasa Y. Vascul Pharmacol; 2018 Nov 01; 110():31-41. PubMed ID: 30071297 [Abstract] [Full Text] [Related]
53. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension. Liu A, Schreier D, Tian L, Eickhoff JC, Wang Z, Hacker TA, Chesler NC. Am J Physiol Heart Circ Physiol; 2014 Aug 01; 307(3):H273-83. PubMed ID: 24906919 [Abstract] [Full Text] [Related]
54. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension. Akazawa Y, Okumura K, Ishii R, Slorach C, Hui W, Ide H, Honjo O, Sun M, Kabir G, Connelly K, Friedberg MK. J Appl Physiol (1985); 2020 Aug 01; 129(2):238-246. PubMed ID: 32644912 [Abstract] [Full Text] [Related]
55. Dimethylarginine dimethylaminohydrolase 1 deficiency aggravates monocrotaline-induced pulmonary oxidative stress, pulmonary arterial hypertension and right heart failure in rats. Wang D, Li H, Weir EK, Xu Y, Xu D, Chen Y. Int J Cardiol; 2019 Nov 15; 295():14-20. PubMed ID: 31402164 [Abstract] [Full Text] [Related]
56. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension. Shults NV, Kanovka SS, Ten Eyck JE, Rybka V, Suzuki YJ. J Am Heart Assoc; 2019 Mar 05; 8(5):e011227. PubMed ID: 30807241 [Abstract] [Full Text] [Related]
57. Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca2+ handling dysfunction in rats with pulmonary artery hypertension. Fowler ED, Drinkhill MJ, Norman R, Pervolaraki E, Stones R, Steer E, Benoist D, Steele DS, Calaghan SC, White E. J Mol Cell Cardiol; 2018 Jul 05; 120():74-83. PubMed ID: 29807024 [Abstract] [Full Text] [Related]
58. Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension. Nakata TM, Tanaka R, Yoshiyuki R, Fukayama T, Goya S, Fukushima R. J Cardiovasc Pharmacol; 2015 Jun 05; 65(6):640-8. PubMed ID: 25806612 [Abstract] [Full Text] [Related]